Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
Charles Okyere Boadu, Medical Laboratory Science Student at the University for Development Studies, shared on LinkedIn:
”Donating blood may protect more than patients.
It could help lower the risk of stroke and organ damage in some donors.
We all know that donating blood saves lives for patients battling cancer, undergoing surgery, surviving trauma, or managing chronic illnesses.
But beyond saving others, blood donation can sometimes help save your own life too.
Many people rarely go for routine medical check ups unless they feel sick.
Yet every time you donate blood, you go through a mandatory screening process including a haemoglobin test.
This simple test works like a mini health check and can reveal important clues about your internal health.
For example, some people unknowingly live with Polycythemia Vera, a rare condition where the body produces too many red blood cells.
Most people with this condition has no early symptoms, so it can remain hidden for a long time.
During donor screening, an unusually high haemoglobin level can become an early warning sign.
The laboratory scientist can then prompt the donor to visit the hospital for further checks, monitoring, education, and treatment.
In people diagnosed with Polycythemia Vera, therapeutic venesection is often done to reduce the thickness of the blood and lower the risk of complications.
If this condition is not detected early, the blood can become too thick and lead to life threatening complications such as stroke, heart attack, and other cardiovascular problems.
Imagine walking in to donate blood to save a stranger and discovering a condition that was silently threatening your own future.
The lesson is simple. When you step forward to save a life through blood donation, you may also uncover hidden health conditions that help protect your own life.
Donate blood. Save lives and possibly your own too.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS